SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-149499
Filing Date
2023-05-19
Accepted
2023-05-19 17:15:04
Documents
14
Period of Report
2023-05-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d465594d8k.htm   iXBRL 8-K 25980
2 EX-5.1 d465594dex51.htm EX-5.1 9973
6 GRAPHIC g465594g0519100807061.jpg GRAPHIC 2484
  Complete submission text file 0001193125-23-149499.txt   166008

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20230519.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20230519_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20230519_pre.xml EX-101.PRE 11261
8 EXTRACTED XBRL INSTANCE DOCUMENT d465594d8k_htm.xml XML 3390
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 23941484
SIC: 2834 Pharmaceutical Preparations